(a) The Department shall identify up-to-date, evidence-based, written information about opioid use disorder that:
(1) Has been reviewed by medical experts and national and local organizations specializing in the treatment of opioid use disorder;
(2) Is designed for use by health care providers and individuals with opioid use disorder and their families;
(3) Is culturally and linguistically appropriate for potential recipients of the information; and
(4) Includes information addressing:
(i) The signs and symptoms of opioid use disorder;
(ii) The risks associated with untreated opioid use disorder;
(iii) Appropriate clinical treatment for opioid use disorder, including:
1. Counseling services; and
2. All medications approved by the U.S. Food and Drug Administration for the treatment of opioid use disorder;
(iv) Appropriate use of overdose reversal agents;
(v) Appropriate support services, including:
1. Peer fellowship and support groups, such as Narcotics Anonymous and Alcoholics Anonymous;
2. Community-based services; and
3. Residential or recovery housing services; and
(vi) Appropriate treatments for pain that may be used to reduce or replace opioid medication treatments for chronic pain.
Dissemination of information to health care facilities and providers
(b)(1) The Department shall provide the information identified by the Department under subsection (a) of this section to health care facilities and health care providers that provide treatment for opioid use disorder.
(2) A health care facility or health care provider shall make the information available to each patient treated by the facility or provider for opioid use disorder.
Credits
Added by Acts 2017, c. 571, § 1, eff. June 1, 2017; Acts 2017, c. 572, § 1, eff. June 1, 2017.
MD Code, Health - General, § 8-407, MD HEALTH GEN § 8-407
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
